Your browser is no longer supported. Please, upgrade your browser.
AWH Aspira Women's Health Inc. daily Stock Chart
Aspira Women's Health Inc.
Index- P/E- EPS (ttm)-0.15 Insider Own1.50% Shs Outstand103.20M Perf Week9.63%
Market Cap498.70M Forward P/E- EPS next Y-0.17 Insider Trans142.86% Shs Float51.13M Perf Month26.12%
Income-15.20M PEG- EPS next Q-0.04 Inst Own28.90% Short Float22.25% Perf Quarter62.59%
Sales4.50M P/S110.82 EPS this Y-8.50% Inst Trans6.13% Short Ratio16.15 Perf Half Y44.85%
Book/sh0.14 P/B34.14 EPS next Y-13.30% ROA-103.90% Target Price- Perf Year529.03%
Cash/sh0.18 P/C26.53 EPS next 5Y- ROE-169.70% 52W Range0.53 - 5.78 Perf YTD490.12%
Dividend- P/FCF- EPS past 5Y19.90% ROI-152.80% 52W High-17.30% Beta3.08
Dividend %- Quick Ratio4.40 Sales past 5Y12.50% Gross Margin33.70% 52W Low800.19% ATR0.28
Employees52 Current Ratio4.40 Sales Q/Q-7.70% Oper. Margin- RSI (14)64.95 Volatility6.05% 6.60%
OptionableYes Debt/Eq0.15 EPS Q/Q-5.60% Profit Margin- Rel Volume0.62 Prev Close4.80
ShortableYes LT Debt/Eq0.12 EarningsNov 12 AMC Payout- Avg Volume704.48K Price4.78
Recom1.50 SMA206.48% SMA5026.66% SMA20065.56% Volume435,060 Change-0.42%
Oct-30-20Initiated William Blair Outperform
Nov-29-20 08:24PM  
Nov-19-20 08:00AM  
Nov-14-20 07:24AM  
Nov-12-20 04:01PM  
Nov-10-20 08:30AM  
Nov-09-20 08:00AM  
Nov-05-20 08:00AM  
Nov-04-20 08:00AM  
Oct-28-20 08:00AM  
Oct-14-20 08:00AM  
Oct-09-20 08:00AM  
Oct-08-20 03:30PM  
Oct-06-20 07:57AM  
Sep-28-20 08:30AM  
Sep-15-20 05:01PM  
Sep-08-20 11:44AM  
Aug-22-20 10:01AM  
Aug-14-20 03:51PM  
Aug-13-20 04:01PM  
Jul-31-20 09:23AM  
Jul-08-20 06:30AM  
Jul-01-20 11:23AM  
Jun-29-20 08:00AM  
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. The company provides sells OVA1, Overa, and Ova1PLUS risk of malignancy tests for ovarian cancer. It also offers ASPiRA GenetiX, a genetic test for specific women's health diseases. In addition, the company owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, it is developing diagnostic algorithms, as well as a high-risk screening algorithm for patients who are genetically predisposed to ovarian cancer. Aspira Women's Health Inc. has entered into a collaborative research agreement with Baylor Genetics to co-develop a novel ovarian cancer early-detection test. It serves physicians, physician office laboratories, and hospital laboratories. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was founded in 1993 and is headquartered in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHREIBER DAVIDDirectorSep 08Sale2.7850,000139,000185,018Sep 10 05:35 PM
SCHULER JACK W10% OwnerJul 01Buy3.502,285,7158,000,00325,394,517Jul 06 05:25 PM